Quantification of these subsets across healthy volunteers and COVID‐19 patients demonstrated an increase in TCM CTLA‐4+ regulatory T cells and IL‐10‐producing regulatory T cells in severe COVID‐19 patients, with mild‐to‐moderate patients being intermediate (Figure 3c). Here, IL10 is linked to COVID-19.